Alnylam Pharmaceuticals
ALNY
#634
Rank
C$44.51 B
Marketcap
$345.10
Share price
-0.80%
Change (1 day)
53.89%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company